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Abstract
Background: Biliary atresia (BA) is a human infant disease with inflammatory fibrous obstructions in the bile
ducts and is the most common cause for pediatric liver transplantation. In contrast, the sea lamprey undergoes
developmental BA with transient cholestasis and fibrosis during metamorphosis, but emerges as a fecund adult.
Therefore, sea lamprey liver metamorphosis may serve as an etiological model for human BA and provide pivotal
information for hepatobiliary transformation and possible therapeutics.
Results: We hypothesized that liver metamorphosis in sea lamprey is due to transcriptional reprogramming that
dictates cellular remodeling during metamorphosis. We determined global gene expressions in liver at several
metamorphic landmark stages by integrating mRNA-Seq and gene ontology analyses, and validated the results
with real-time quantitative PCR, histological and immunohistochemical staining. These analyses revealed that gene
expressions of protein folding chaperones, membrane transporters and extracellular matrices were altered and
shifted during liver metamorphosis. HSP90, important in protein folding and invertebrate metamorphosis, was
identified as a candidate key factor during liver metamorphosis in sea lamprey. Blocking HSP90 with geldanamycin
facilitated liver metamorphosis and decreased the gene expressions of the rate limiting enzyme for cholesterol
biosynthesis, HMGCoA reductase (hmgcr), and bile acid biosynthesis, cyp7a1. Injection of hsp90 siRNA for 4 days
altered gene expressions of met, hmgcr, cyp27a1, and slc10a1. Bile acid concentrations were increased while bile
duct and gall bladder degeneration was facilitated and synchronized after hsp90 siRNA injection.
Conclusions: HSP90 appears to play crucial roles in hepatobiliary transformation during sea lamprey metamorphosis.
Sea lamprey is a useful animal model to study postembryonic development and mechanisms for hsp90-induced
hepatobiliary transformation.
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Background
Metamorphosis represents a dramatic and large-scale
morphological and functional change during post-
embryonic development in free-living larvae of inver-
tebrates and non-mammalian vertebrates including
fishes, amphibians, and reptiles [1–6]. It has been ex-
tensively studied in insects and amphibians, and its
developmental process is tightly controlled by hor-
mones [5]. In general, metamorphosis in vertebrates is
a single, uninterrupted larval-adult transition, whereas
in insects and some other invertebrates, it proceeds
through multiple larval and pupal moults, each re-
peated with a qualitatively similar hormonal inter-
action [5]. This distinction is exemplified for distinct
pulses of ecdysone just preceding each larval and
pupal moult in Manduca sexta and the single burst of
triiodothyronine (T3) for metamorphosis of Xenopus
larvae to the froglet stage [5].
In most chordates studied to date, the onset of meta-
morphosis is characterized by a peak of a thyroactive
compound, activating the thyroid receptor that modifies
the expression of target genes and leads to morpho-
logical remodeling characteristic of the larva-to-juvenile
transition [4]. However, thyroid hormone did not seem
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to be the main factor controlling hind limb development
in tadpoles [7] and metamorphosis in sea lamprey
(Petromyzon marinus Linnaeus) [8–14]. In fact, there is
a drop in circulatory thyroid hormone levels prior to meta-
morphosis, and treatment of thyroid hormones per se failed
to induce metamorphosis in sea lamprey [8–14].
In invertebrates, HSP90 seems to be the main factor
controlling metamorphosis. Blocking HSP90 function
with geldanamycin triggers metamorphosis in protozoan
Leishmania parasites [15] and in all major branches of
metazoa including nematodes [16], molluscs [17] and
sea urchin to tunicates [18, 19]. The sea lamprey, a
jawless vertebrate, diverged from urochordates 550
million years ago [20–22]. The developmental control of
sea lamprey metamorphosis may be an evolutionary
intermediate between the HSP90-dependent invertebrate
form and thyroid hormone-dependent vertebrate form
[1]. Therefore, the sea lamprey presents a unique model
to study the evolutionary transition of developmental
control during metamorphosis.
The sea lamprey develops through distinct life stages
[23, 24]. After hatching, larval sea lamprey live in bur-
rows as benthic filter feeders. After seven metamorphic
stages of dramatic change in external morphology and
reorganization of internal organs [25], the emerging ju-
veniles (JV) enter a parasitic phase during which they
feed on blood and tissue fluid from host fish. After 1.5
to 2 years feeding in the ocean or large lakes, the adults
cease feeding in the early spring and migrate into rivers
to spawn and die [23, 24].
The hepatobiliary system undergoes the most dramatic
changes during sea lamprey metamorphosis, compared
to other organs such as the intestine and the kidney
[26–28]. The cholangiocytes lining the extrahepatic bile
duct and the gallbladder undergo apoptosis starting at
the onset of metamorphosis (late larval stage; L), with
the most dramatic morphological changes at meta-
morphic stage 2 (M2) and full degeneration at meta-
morphic stage 3 [26–28]. Occasionally one or two
intrahepatic bile ducts persist into metamorphic stages 5
and 6, but usually disappear by stage 7 [27, 28]. The hepa-
tocytes cease bile acid synthesis in the early metamorphic
stages, undergo cyto-architectural reorganization, eventu-
ally resume bile acid synthesis at metamorphic stage 5
(M5) and proliferate to fill the space once occupied by the
biliary system [27–30]. Despite thorough characterization
of the cellular and organ-level morphological changes
during sea lamprey metamorphosis, the developmental
regulation of the hepatobiliary transformation is not fully
understood.
We hypothesized that the hepatobiliary transformation
during sea lamprey metamorphosis was due to transcrip-
tional reprogramming that dictated cellular remodeling
during metamorphosis, especially in landmark stages (L,
M2, M5 and JV). We compared sea lamprey hepatobili-
ary transcriptomes at these landmark stages using
mRNA-Seq and gene ontology (GO) analyses, and vali-
dated the sequencing results with real-time quantitative
PCR (RTQ-PCR), histological and immunohistochemical
staining, and antagonist and siRNA blocking experi-
ments. Our results suggest that hsp90 may be critical for
the transformation of the hepatobiliary system during
sea lamprey metamorphosis.
Results
Hepatobiliary transcriptome reprogramming during liver
metamorphosis
We sequenced and compared the liver transcriptomes of
L, M2, M5 and JV stages (Fig. 1). All sequencing reads
were 75mers. From the L liver, 21,357,947 reads were
sequenced, and 70.2 % of them passed the quality fil-
ter (14,985,824 reads). From the M2 liver, 19,272,978
reads were sequenced and 76.5 % of them passed the
quality filter (14,747,950 reads). The M5 liver pro-
duced 22,479,660 reads, and 66.0 % of them passed
the quality filter (14,834,568 reads). The JV liver pro-
duced 20,649,552 reads, and 70.2 % of them passed
the quality filter (14,490,540 reads). These sequences
were assembled and aligned to a total of 3246 genes,
and these genes were clustered into 5297 GO categor-
ies. The GO analyses compared differential expression
(≥2-fold difference) between the transcriptomes of dif-
ferent life stages.
Comparison of L and M2 liver transcriptomes revealed
that 88 GO categories and 248 genes were expressed at
least 2-fold higher in L, whereas 8 GO categories and 44
genes were expressed at least 2-fold higher in M2. Gene
ontology categories related to developmental and meta-
bolic processes and cell division (mitosis) were more
active in L compared to M2 (legends for x-axis, Fig. 1a).
Signaling pathways (phosphoinositide-mediated and
second-messenger-mediated signaling) and cytokine
production were also higher in L compared to M2
(Fig. 1a). On the contrary, genes involved in protein
folding and transmembrane transport were up-regulated
at M2 compared to L (Fig. 1b). At M2, the response to
extracellular and external stimuli, and nutrient levels also
increased compared to L (Fig. 1b). Phospho-histone
3 (p-H3, a mitotic marker) immunostaining con-
firmed that cell division was occurring in hepatocytes
(Fig. 2, a–f ). On the other hand, cholangiocytes were
apoptotic and degenerated, as indicated by alkaline phos-
phatase staining (Fig. 2, g–l).
Comparison of M2 and M5 liver transcriptomes revealed
that 16 GO categories and 106 genes were expressed at
least 2-fold higher at M5. Tissue development, lipid
metabolic processes, cell division, and phosphoinositide-
mediated signaling pathways were higher in M5 compared
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to M2 (legends for x-axis, Fig. 1c). Phospho-histone 3
immunostaining confirmed that cell division was occurring
in hepatocytes (Fig. 2, a–f). Most bile ducts disappeared by
M4 (Fig. 2).
Comparison of M5 and JV liver transcriptomes re-
vealed that 31 GO categories and 111 genes were
expressed at least 2-fold higher in JV, mostly related to
increased small molecule and organic acid (including
bile acid) metabolism in the liver (legends for x-axis,
Fig. 1d). Cell proliferation was reduced at JV (p-H3 im-
munostaining, Fig. 2f ), and apoptosis was rarely detected
(alkaline phosphatase staining, Fig. 2l).
Differential transporter gene expression during liver
metamorphosis
The transporters expressed at landmark metamorphic
stages varied dramatically (Table 1), and provided a
snapshot of the essential factors required at each meta-
morphic stage. It appeared that liver transporter gene
expressions shifted during sea lamprey metamorphosis.
At L, transporters for phospholipids or fatty acids, Ca2+,
amino acids, peptides or oligopeptides were more
prominent than M2. At M2, metabolism and bile acid
transport were down-regulated, whereas the gene ex-
pressions of transporters for wound healing molecules
(thiamin and vitamin C) and cytoprotective agents such
as taurine were dramatically increased. Bile salt export
pump (bsep) gene expression increased at later meta-
morphic stages and JV (Fig. 3). Expression of bile acid
co-transporter slc10a1 was increased in JV, but not at
M2 (Table 1, Fig. 3).
HGF and MET promote hepatocyte regeneration during
liver metamorphosis
Real time quantitative PCR analyses of liver gene expres-
sions throughout various life stages revealed that hepato-
cyte growth factor (hgf ), a hepatocyte proliferating
agent, increased at M4, whereas its receptor met peaked
at M2 (Fig. 3). These results demonstrated that hgf gene
(C) M5 > M2 (D) JV > M5
(B) M2 > L(A) L > M2
Fig. 1 Gene ontology (GO) analyses of liver transcriptomes in metamorphic land mark stages. X-axis represents the GO categories and Y-axis
represents gene clusters (listed in Additional file 1). Color scale represents the Log2 (transcript number in transcriptome 1/transcript number in
transcriptome 2). Only genes with 2-fold changes (or greater) are shown. a Heat map showing GO categories at least 2-fold higher in larval (L)
compared to metamorphic stage 2 (M2), p < 0.05, false discovery rate≤ 0.1. b Heat map showing GO categories at least 2-fold higher in M2
compared to L, p < 0.05, false discovery rate ≤ 0.1. c Heat map showing GO categories at least 2-fold higher in metamorphic stage 5
(M5) compared to M2, p < 0.05, false discovery rate ≤ 0.1. d Heat map showing GO categories at least 2-fold higher in newly transformed
juvenile (JV) compared to M5, p < 0.05, false discovery rate ≤ 0.1
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expression peaked at the metamorphic stage with height-
ened hepatocyte proliferation (M4).
Alteration of Extracellular Matrix (ECM) composition
during liver metamorphosis
The extracellular matrix (ECM) composition changed
during liver metamorphosis (Table 2). Collagen gene
col3a1 expression peaked at L stage whereas col2a1 ex-
pression peaked at JV stage (Table 2). Collagen genes
col1a2, col4a4, and col5a2, as well as laminin lamc1 were
up-regulated from M2 to JV stages, whereas col12a1 was
down-regulated during metamorphosis (Table 2). Collagen
genes col4a6, col5a1, and col6a2 were down-regulated
only at M2 while col4b6 was down-regulated at L and M2
(Table 2). The general trend was a transition from col1a1
to col1a2 for Type I collagen, a switch from Type III to
Type II collagens, an induction from a single subtype to
multiple subtypes for Type IV and Type V collagens, and
the increase in the non-collagenous constituent of the
basement membrane lamc1. Type VI and Type XII col-
lages were generally down-regulated during metamor-
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Fig. 2 Hepatocyte proliferation and cholangiocyte apoptosis during liver metamorphosis. a–f: Mitosis marker phospho-histone 3 immunostaining
(brown) in liver section at various metamorphic stages. Paraffin sections (4 μm) were stained with DAB and counterstained with hematoxylin
(blue/purple) nuclear stain. Note that staining is localized only in hepatocytes. g–l: Apoptosis marker alkaline phosphatase staining (dark purple)
in liver section at various metamorphic stages. Paraffin sections (4 μm) were stained with alkaline phosphatase (AP) substrate NBT/BCIP and
counterstained with nuclear Fast Red (pink/red stain). In larval (L) and metamorphic stages 1 (M1) and 2 (M2), AP activity was located in canaliculi
between hepatocytes and the lumen lining of the cholangiocytes. In metamorphic stage 3 (M3), AP activity was located in canaliculi between
hepatocytes, blood cells and whole cholangiocytes. In metamorphic stage 4 (M4), only a few blood cells contain AP activity. In newly transformed
juvenile (JV), no AP activity was detected. Scale bar: 50 μm. BD: bile duct; H: hepatocyte
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Table 1 Transporter gene expression at various metamorphic stages
Transporters Transported molecules L M2 M5 JV
abca1 Cholesterol + + + +
abcb4 Phosphotidylcholine (hepatocyte to bile) + ++
abcb6 Unknown (Half transporter, mitochondrial) ++ +
abcb9 Unknown (Half transporter, lysosomal) + ++
abcc5 Cyclic nucleotide + ++
abcd2 Fatty acid, fatty acyl-CoA (Half transporter, peroxisomal) ++
abcg2 Xenobiotic + ++
atp1a2 Na+/K+ + ++ ++
atp1b3 Na+/K+ + ++ +++
atp2a1 Ca2+ (cytosol to ER) + ++
atp2a2 Ca2+(cytosol to ER) ++ +
atp2b1 Ca2+ (Plasma membrane) + ++
atp5j2 H+ (Mitochondrial) + ++
atp5o H+ (Mitochondrial) + ++ ++
atp6v1f H+ (Mitochondrial) + ++
atp6v1h H+ (Mitochondrial) + ++
atp8a1 Aminophospholipid (phosphotidyl serine) ++ +
atp10d Phospholipid ++ + ++
slc1a1 Glu + ++
slc2a9 Glucose ++ +
slc4a4 Na+, bicarbonate ++ +
slc4a11 Na+, borate ++ + ++ ++
slc5a6 Na+, vitamin (pentothenate, biotin, lipoate) + ++ + +++
slc5a7 Na+, Cl-/Choline + ++ +
slc6a2 Na+, NE + ++
slc6a6 Na+/taurine, β-Ala + ++ +
slc6a8 Creatine + ++
slc6a12 GABA, betaine ++ + ++ +++
slc7a1 Cationic amino acid ++
slc7a5 Cationic amino acid ++ + ++
slc7a6 Na+/cationic amino acid ++ + ++
slc7a8 Neutral amino acid + ++ +
slc7a11 Cationic amino acid ++ + ++ ++
slc9a7 Na+/H+ + ++ + +++
slc10a1 Na+, bile acids (basal) ++ ++ +++ ++++
slc12a2 Na+/K+/Cl- ++ +
slc12a6 K+, Cl- ++ + ++ +++
slc15a1 H+/peptide ++ + ++
slc15a2 H+/peptide ++ + ++
slc16a4 H+/monocarbohydrates + ++ ++ +++
slc18a2 Monoamine (vesicular) ++ +
slc19a2 Thiamine + ++
slc20a1 Na+, phosphate + ++
slc20a2 Na+, phosphate + ++ +++ +++
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and col4 gene expressions were consistent with the tran-
scriptome results (Fig. 3). Picro Sirius Red staining for col-
lagen fibers revealed a transient fibrosis during liver
metamorphosis, which later cleared (Fig. 4).
Hsp90 gene expression altered at landmark
developmental event
Transcriptome analyses revealed that genes involved in
protein folding were up-regulated at M2 when the most
dramatic metamorphic events occurred. Hsp90 was iden-
tified as a candidate key factor during liver metamor-
phosis because of its involvement in protein folding [31],
metamorphosis in invertebrates [15, 18], and human
biliary atresia [32]. Increased hsp90 mRNA expression
coincided with the onset (M1), gall bladder disappear-
ance (M3), and final stages (M6-M7) of metamorphosis
(Fig. 5). Sharp declines of hsp90 mRNA concentrations
also demarcated the heightened biliary degeneration
stage (M2) and transitions in metamorphic and life
stages, for example: metamorphic stage 7 (M7) to newly-
transformed juvenile (T), small parasite (SP) to large
parasite (LP), pre-ovulatory female (POF) to ovulatory
female (OF), and pre-spermiating male (PSM) to sper-
miating male (SM) (Fig. 5).
The HSP90 blocker geldanamycin facilitated and
hsp90 siRNA synchronized gall bladder degeneration
during liver metamorphosis in sea lamprey (Table 3;
Additional file 1). The vehicle control group showed a
wide range of gall bladder sizes (1.775 ± 0.300 mm,
mean ± S.E.M) whereas the gall bladder of the hsp90
siRNA-treated group was more homogeneous in sizes
(1.833 ± 0.102 mm, mean ± S.E.M.) (F-test, dF = 7, p <
0.05). Geldanamycin treatment decreased the rate-
limiting enzymes in the cholesterol (hmgcr) and classical
bile acid (cyp7a1) synthetic pathways, but did not alter
the expression of hsp90 (Fig. 6). In addition, hsp90
siRNA treatment altered the gene expressions of met
(receptor for hepatocyte growth factor), hmgcr, slc10a1
and the rate-limiting enzyme for alternative bile acid
synthetic pathway, cyp27a1 (Fig. 7), but had no effect on
cyp7a1. Bile acid concentrations were increased 4 days
and 4 months after hsp90 siRNA injection (Fig. 8). Bile
duct degeneration was facilitated at 4 months after
hsp90 siRNA injection (Fig. 9).
Discussion
We hypothesized that transcriptional reprogramming in
landmark stages (L, M2, M5 and JV) drove hepatobiliary
transformation during sea lamprey metamorphosis. Our
results showed that hepatobiliary transcriptome repro-
gramming occurred at landmark stages during meta-
morphosis. The transporter genes and the ECM gene
composition were altered during liver metamorphosis,
and the histological and morphological changes during
Table 1 Transporter gene expression at various metamorphic stages (Continued)
slc22a3 Organic cations + ++ + ++
slc22a18 Organic cations + ++
slc23a1 Vitamin C + ++ +
slc23a2 Vitamin C + ++ +
slc25a1 Citrate-H+, malate (Mitochondrial) + ++ ++ +++
slc25a3 Phosphate (cytosol to mitochondrial) + ++
slc25a5 ADP (mitochondrial to cytosol) + ++
slc25a13 H+/Asp, Glu (mitochondrial) + ++
slc25a26 Metabolites, cofactors (mitochondrial) ++
slc25a36 Unknown ++
slc26a5 Cl-, bicarbonate + ++
slc27a6 Fatty acid ++ +
slc29a1 Nucleoside ++
slc30a1 Zn2+ ++
slc30a2 Zn2+ ++++ +++ ++ ++
slc35a3 UDP-GlcNac ++ +
slc35b1 UDP-galactose + ++ +
slc35b2 3′-phospho-5′-phosphosulfate + ++
slc35b4 UDP-xylose, UDP-GlcNAc + ++
slc37a4 Glucose-6-phosphate + ++
L larva, M2 metamorphic stage 2, M5 metamorphic stage 5, JV newly transformed juvenile, + expressed with at least 2-fold difference between
paired transcriptomes


























































































































































































































































































































Fig. 3 Differential gene expressions in sea lamprey liver at various metamorphic and life stages. Selected genes: bile salt export pump (bsep),
sodium/bile acid co-transporter (slc10a1), hepatocyte growth factor (hgf), HGF receptor met, collagen col2a1, and collagen col4. a: significantly
different from larval (L) group; b: significantly different from metamorphic stage 1 (M1); c: significantly different from M2; d: significantly different
from M3; e: significantly different from M4; f: significantly different from M5; g: significantly different from M6; h: significantly different from M7; i:
significantly different from newly transformed juvenile (JV); j: significantly different from pre-ovulatory female (POF); k: significantly different from
pre-spermiating male (PSM) group; l: significantly different from ovulatory female (OF); m: significantly different from spermiating male (SM); *:
significantly different from all other groups (ANOVA test followed by post hoc test, p < 0.05). A: adult; LP: large parasite; SP: small parasite. Number
on each bar represents the number (n) of lamprey in each group
Table 2 Extracellular matrix gene expression at various metamorphic stages
Symbol Full name L M2 M5 JV
col1a1 Collagen, Type I, Alpha-1 + +
col1a2 Collagen, Type I, Alpha-2 + ++ +
col2a1 Collagen, Type II, Alpha-1 +
col3a1 Collagen, Type III, Alpha 1 +
col4a4 Collagen, Type IV, Alpha 4 ++ + +
col4a6 Collagen, Type IV, Alpha 6 + + +
col4b6 Collagen, Type IV, Beta 6 + +
col5a1 Collagen, Type V, Alpha 1 + ++ ++
col5a2 Collagen, Type V, Alpha 2 + ++ ++
col6a2 Collagen, Type VI, Alpha 2 ++ ++ +
col12a1 Collagen, Type XII, Alpha 1 + ++
lamc1 Laminin, Gamma 1 + + +
muc5ac Mucin 5 AC, Oligomeric Mucus/Gel-Forming +++ ++ +
L larva, M2 metamorphic stage 2, M5 metamorphic stage 5, JV newly transformed juvenile, + expressed with at least 2-fold difference between
paired transcriptomes
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liver metamorphosis also paralleled the transcriptome
reprogramming. These results are similar to the
remodeling through “gene switching” observed in
Xenopus laevis liver metamorphosis [33]. The changes
in liver ECM composition also occurred during the
transition from liver fibrosis and steatohepatitis to
hepatocellular carcinoma [34].
Type IIA col2a1 mRNA was the major form of tran-
script found in most nonchondrogenic tissues of early
human embryos [35]. Similar to observations in the
mouse, expression of col2a1 transcripts in human em-
bryos was generally transient and was found in epithelial
structures that participated in epithelial-mesenchymal
interactions [35]. Expression of col2a1 mRNA was asso-
ciated with major tissue remodeling such as hepatic cord
development in the liver [35]. A previous morphological
study showed that the onset of bile duct degeneration
was demarcated by the folding and pleating of the base-
ment membrane [27]. It is likely that the disintegration
and reorganization of the basement membrane was as-
sociated with the early events of liver metamorphosis.
Indeed, the breakdown of basement membranes was
an important step in the controlled rearrangement of
cells during metamorphosis [36]. Our observation of
transient fibrosis during liver metamorphosis is
consistent with these prior demonstrations that
reorganization of collagen fibers plays a significant
role in liver metamorphosis.
The cholangiocytes degenerated during liver metamor-
phosis in the sea lamprey, similar to those from analyses
of Japanese lamprey (Lethenteron reissneri) metamor-
phosis, which showed that the apoptotic signal was initi-
ated in the region around the cystic duct, and the
smaller peripheral ducts degenerate more rapidly than
the large central ducts [37]. Our results are also consist-
ent with previous findings that membrane enzymes such
as alkaline phosphatase relocated from apical to lateral
membranes during lamprey BA [38].
Apoptosis of cholangiocytes in liver allograft rejection
was attributed to down-regulation of the apoptosis-
inhibitory BCL-2 protein [27]. Our transcriptome data
showed that the gene expression of bcl-2 was the highest
at L stage compared to M2 and M5 (no difference be-
tween M2 and M5) and the lowest at JV stage. Between
M2 and M5, sea lamprey transitions from the ductal to
aductal stage, and cholangiocytes undergo apoptosis and
degenerate. At JV stage, the liver of the transformed ani-
mal is totally aductal without any cholangiocytes. It is in-
teresting that BCL-2 protein is absent in the early stage
of human intrahepatic biliary system development, but
present in the late stage [38], and apoptosis can be in-
duced by the purine-scaffold HSP90 inhibitor PU-H71
via down-regulation of Bcl-2 [39]. In addition, inhibition
of the molecular chaperone function of HSP90 by
geldanamycin induces endoplasmic reticulum (ER)
stress-mediated apoptosis in different cell lines [40–42].
L M1 M2
M3 T JV
Fig. 4 Collagen fiber reorganization during liver metamorphosis in sea lamprey. Transient fibrosis (thickened red collagen deposit) was observed
around proliferating bile ducts during liver metamorphosis. Paraffin sections were stained with Picro Sirius Red (Gladstone). Scale bar: 50 μm. L:
larval stage, M1-3: metamorphic stages 1 –3, T: newly transformed juvenile, JV: juvenile
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It would seem that at L stage, low hsp90 and high bcl-2
expressions might protect against apoptosis.
The hepatocytes underwent mitosis during liver
metamorphosis, indicated by some nuclear and mostly
cytoplasmic staining of p-H3, a mitotic marker. H3
phosphorylation has been shown to initiate at early pro-
phase, and spread throughout the chromosomes at late
prophase. At metaphase, most of the p-H3 aggregates at
the ends of the condensed chromosomes at the equator-
ial plate. During anaphase and telophase, p-H3 is usually
detached from chromosomes and found in the cyto-
plasm [43]. Our results indicated that most of the hepa-
tocytes with p-H3 staining were at anaphase or
telophase. Interestingly, histones could induce profound
changes in the autophosphorylation of HSP90 [44], and
the direct interaction of HSP90 and histones induced
condensation of the chromatin structure [45] and de-
creased overall transcription activity [46]. HSP90 is evo-
lutionarily conserved and essential for the maturation,
activation and stability of “client” proteins that regulate
proliferation, cell cycle and survival [31, 47]. Therefore,
HSP90 could contribute to the activity of H3 phosphor-
ylation and cell proliferation.
HGF has been shown to have potent effects on hepatic
growth and differentiation [48–52]. It functioned as a
complete mitogen for hepatocytes [53] and produced an
anti-apoptotic effect [54, 55]. The MET signaling cascade
is also a major player in liver development and differen-
tiation [53–55]. It is possible that HGF and MET facili-
tated hepatocyte regeneration during sea lamprey
metamorphosis. Interestingly, MET and its downstream
effectors were also HSP90 clients [56, 57]. HGF and
MET were both present in intrahepatic biliary system
(IBS) cells in the early stage of human IBS development
[38]. Inhibition of HSP90 increased hgf gene expression
[58], and HSP90 inhibitor exhibited antineoplastic and
antiangiogenic activity via MET [59]. It appears that
hsp90 is tightly linked to the activity of met during liver
metamorphosis in sea lamprey.
Gene expression of hsp90 decreased during metamor-
phosis but dramatically increased after metamorphosis in
sea lamprey liver. This is consistent with the finding that
blocking HSP90 function with the HSP90 inhibitor gelda-
namycin triggered metamorphosis in tunicates [19]. The
transition from larval to adult stages in marine inverte-
brates was tightly regulated by an environmentally-
sensitive competent period that delayed metamorphosis
until the proper cues were detected by the larvae [60–62].
In sea urchins and ascidians, HSP90 inhibitors triggered
metamorphosis when applied during the competent
period [15]. HSP90 and its substrates were also involved
in life-cycle transitions of Leishmania parasites [16] and
the metamorphosis of species spanning all major branches
of metazoan phylogeny, from insects and nematodes [18],
to echinoderms [60], ascidians [17] and mollusks [63].
Even in the amphibian, other members of the hsp fam-
ily such as hsp30s played an important role in the




























































































































































Fig. 5 Hsp90 gene expression during various metamorphic and life
stages in the liver of sea lamprey. Increased hsp90 mRNA expression
coincided with the onset (M1), gall bladder disappearance (M3), and
final stages (M6-M7) of metamorphosis. Sharp declines of hsp90
mRNA concentrations also demarcated the heightened biliary
degeneration stage (M2) and the transition in life stages (M→ T,
SP→ LP, POF→OF, and PSM→ SM). a: significantly different from
larval (L) group; b: significantly different from metamorphic stage 1
(M1); c: significantly different from M2; d: significantly different from
M3; e: significantly different from M4; f: significantly different from
M5; g: significantly different from M6; h: significantly different from
M7; i: significantly different from newly transformed juvenile (JV); j:
significantly different from small parasite (SP); k: significantly different
from large parasite (LP); l: significantly different from pre-ovulatory
female (POF); m: significantly different from ovulatory female (OF);
n: significantly different from pre-spermiating male (PSM); o: significantly
different from spermiating male (SM); *: significantly different from all
other groups (ANOVA test followed by post hoc test, p< 0.05). Number
on each bar represents the number (n) of lamprey in each group
Table 3 HSP90 antagonist geldanamycin facilitates
metamorphosis in sea lamprey
Metamorphic stage Frequency in the
control group










Fully transformed juvenile 0 0
χ2 = 12.581, DF = 3, p = 0.0056

























































n = 11 n = 10
Fig. 6 Geldanamycin (HSP90 inhibitor) decreased cyp7a1and HMGCoA reductase (hmgcr) transcriptions in sea lamprey liver. *: significantly



























































































































Fig. 7 Hsp90 siRNA treatment altered gene expressions in sea lamprey liver during metamorphosis. Hsp90 siRNA treatment increased met,
HMGCoA reductase (hmgcr), and cyp27a1, but decreased slc10a1 gene expressions (t-test and F-test, p < 0.05)





















































Fig. 8 Hsp90 siRNA treatment increased bile acid concentrations in sea lamprey liver during metamorphosis. Hsp90 siRNA treatment increased
bile acids 3 keto-petromyzonol sulfate (3kPZS), petromyzonol sulfate (PZS), allocholic acid (ACA), 3-keto allocholic acid (3kACA), petromyzonol
(PZ), 3 keto-petromyzonol (3kPZ), petromyzonamine disulfate (PADS), and petromyzonsterol disulfate (PSDS) (ANOVA test for repeated measurement,




Fig. 9 Hsp90 siRNA treatment decreased CK19 and BCL2 immunofluorescence in sea lamprey liver during metamorphosis. Confocal images
showing the biliary tree in sea lamprey liver (whole organ processed with a modified CLARITY method [73]) during metamorphosis. Left panels
are taken from the anterior, and the right panels from the posterior end. Images of liver cell surface marker cytokeratin 19 (1:100 mouse-anti-CK19,
Thermo Fisher; stained with 2 μg/ml Alexa Fluor 350-goat-anti-mouse IgG, Life Technologies; blue fluorescence) and anti-apoptotic marker BCL2
(1:100 rabbit-anti-Bcl2, Santa Cruz; stained with 2 μg/ml Alexa Fluor 488-donkey-anti-rabbit IgG, Life Technologies; green fluorescence) are
superimposed. White arrows indicate the biliary tree. Yellow arrows indicate the dead cells and surrounding canaliculi and ductules in the
liver. Note that the biliary tree was mostly degenerated in hsp90 siRNA-treated liver. Scale bar: 500 μm
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metamorphosis from an ammonotelic larva to a ureotelic
adult [64]. Interestingly, we found that HSP90 blocker
geldanamycin facilitated and hsp90 siRNA treatment
synchronized gall bladder degeneration during liver meta-
morphosis in the sea lamprey. Coincidentally, proteomic
analyses comparing BA and non-BA neonatal cholestasis
patients showed that HSP90 was the most significant bio-
marker that was down-regulated in BA patients [32].
Furthermore, we found that the expression of choles-
terol and bile acid synthetic genes such as hmgcr,
cyp7a1, and cyp27a1, and bile acid concentrations were
altered after geldanamycin or hsp90 siRNA injection,
even up to 4 months. These results are consistent with
reports that HSP90 was involved in cholesterol homeo-
stasis [65, 66]. Lipid content was an important determin-
ing factor of lamprey metamorphosis [67], and lipid and
bile acid biosynthesis and metabolism changed dramatic-
ally during sea lamprey metamorphosis [29, 68]. These
results suggest that HSP90 was involved in many aspects
of hepatobiliary transformation. However, geldanamycin
or hsp90 siRNA did not affect hsp90 mRNA concentra-
tion per se at the time points examined. Further time
course analyses are required to establish the actual rela-
tions between hsp90 and all genes affected.
Conclusions
During sea lamprey liver metamorphosis, the ECM may be
associated with the reorganization of the liver architecture.
At the early stage of metamorphosis, the metabolism of he-
patocytes was down-regulated. Extracellular and external
stimuli, nutrient levels, and phosphoinositide-mediated sig-
naling pathways strongly affected the process of liver
metamorphosis. Major shifts in transporter expressions
occurred throughout liver metamorphosis, whereas hepa-
tocytes proliferated at later stages. Once the process of bil-
iary atresia was completed, the metabolism in hepatocytes
resumed. Hsp90 was involved in many aspects of hepato-
biliary transformation including hepatocyte regeneration,
biliary degeneration and changes in bile acid synthesis. We
conclude that the sea lamprey is a useful animal model to
study postembryonic development and mechanisms for
hsp90-induced hepatobiliary transformation.
Methods
Collection and maintenance of animals
All animals received humane care according to the cri-
teria outlined in the “Guide for the Care and Use of
Laboratory Animals” prepared by the National Academy
of Sciences and published by the National Institutes of
Health (NIH publication 86-23 revised 1985) of the
United States. Animal handling procedures were approved
by the Institutional Animal Care and Use Committee at
Michigan State University (MSU).
Larval lampreys, collected by the staff of U.S. Geo-
logical Survey Lake Huron Biological Station or by the
survey crew of U.S. Fish and Wildlife Service Ludington
Biological Station (Ludington, MI, USA), were kept in
plastic tanks (98 × 54 × 48 cm3, length × width × height)
with flow-through water. The bottom of the tanks were
filled with 13 cm of fine sand, which can pass through
No. 18 (1 mm), 3ϕ (125 μm) or 4ϕ (62.5 μm) U.S. stand-
ard sieve. Water tanks were aerated with stone air brea-
kers to keep dissolved oxygen levels in the water near
saturation. The water flow was kept at 10 L/min and the
water temperature at 16 ± 1 °C. Larvae were fed with
dried brewer’s yeast (60 g/100 larvae, suspended in
100 ml water before use) once per week. Larvae that had
started metamorphic processes were checked every other
week. Liver samples were collected from various meta-
morphic stages according to the appearance of eyes, the
structure of oral aperture, the degree of development of
the tongue-like piston, the shape and degree of cornifi-
cation of the teeth, and the coloration of the body [25].
Due to the difficulty of obtaining metamorphic liver
samples, sample sizes varied among experiments.
GO analyses
Transcriptome expression data for sea lamprey liver at
various metamorphic stages were obtained using an Illu-
mina Genome Analyzer II (Illumina, Inc., San Diego,
CA, USA) and mRNA-Seq protocol (75-mers, mRNA-
Seq 8 sample Prep Kit, Illumina) at the Genomics Tech-
nology Support Facility in MSU. Two-way BLASTX
between lamprey transcriptome ESTs and mouse protein
database was performed to obtain putative orthologues.
GO categories were assigned to the corresponding ESTs
according to NCBI/Entrez databases. Bowtie software
was used to quantify the number of reads [69]. The raw
counts were normalized using quantile normalization.
Normalized profiles were pairwise-compared using
GoMiner software [70]. Heat maps were generated using
CIMminer software [71].
Histology and immunohistochemistry
Histological samples were processed in the Investigative
Histopathology Laboratory at MSU. Immunostaining for
p-H3 followed the methods described previously [72].
Negative controls (deprived of the primary antibody)
were performed simultaneously in every immunostaining
experiment. The antibody concentration used for p-H3
was 1:1000 (Sigma; St. Louis, MO, USA). Briefly, paraffin
sections (4 μm) were deparaffinized with xylene and
rehydrated through an ethanol series (100 to 10 %) and
rinsed in Tris buffered saline (TBS: 50 mM Tris,
150 mM NaCl, pH 7.2; 5 min each). All reagents were
diluted with TBS/0.05 % Triton-X100 according to the
manufacturer’s instructions unless mentioned otherwise.
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Sections were incubated in the mixture of primary anti-
body for p-H3 (1:1000, Sigma) and normal goat serum
(Vector Laboratories; Burlingame, CA, USA) over night
at 4 °C. Sections were then incubated in biotinylated sec-
ondary antibody (goat-anti-rabbit IgG, Vector), followed
by ABC solution (Vector), and stained with 3,3′-diami-
nobenzidine (Vector).
Alkaline phosphatase staining followed the methods
described previously [72]. Briefly, paraffin sections were
deparaffinized and rehydrated as described above, incu-
bated with nitroblue tetrazolium chloride and 5-bromo-
4-chloro-3 indolyl phosphate substrate (Roche Applied
Science, Indianapolis, IN, USA) for 3 h, and counter-
stained with Nuclear Fast Red (Vector).
Hsp90 antagonist and siRNA experiments
Hsp90 antagonist experiment
Thirty-three sea lamprey larvae at metamorphic stage 2
(M2) were treated with vehicle (0.05 % dimethyl sulfox-
ide, Sigma; interperitoneal (i.p.) injection) or 5 μM gel-
danamycin (Tocris Bioscience, Park Ellisville, MO, USA;
i.p. injection, 50 μl/ml body volume). Animals were eu-
thanized with 0.02 % MS222 (Sigma) after 1 week. Liver
were snap-frozen in liquid nitrogen and stored at −80 °C
before processing for real-time quantitative PCR.
siRNA experiment I
Twenty sea lamprey larvae at metamorphic stage 2 (M2)
were treated with vehicle (3.3 % lipofectamine, Life
Technologies, Grand Island, NY, USA; i.p. injection) or
53.67 μg/ml hsp90 siRNA (Stealth RNAi duplex with
sense sequence: 5′GCAGCAAAGUGGCGUAUUA3′,
and antisense sequence: 5′UAAUACGCCACUUUGC
UGC3′, Life Technologies; i.p. injection, 50 μl/g body
weight). Animals were euthanized with 0.02 % MS222
after 4 days. Liver were snap-frozen in liquid nitrogen
and stored at −80 °C before processing for real-time
quantitative PCR and LC-MS/MS.
siRNA experiment II
Twenty sea lamprey larvae at metamorphic stage 2 (M2)
were injected with vehicle or hsp90 siRNA as in siRNA
Experiment I every other week (4 injections total). Ani-
mals were euthanized with 0.02 % MS222 after 4 months.
Half of the liver samples were snap-frozen in liquid nitro-
gen and stored at −80 °C before processing for LC-MS/
MS. The other half were fixed in hydrogel and processed
for CLARITY, immunofluorescent staining and confocal
microscopy according to Chung-Davidson et al. [73].
LC-MS/MS analyses of bile acids
Bile acid analyses followed the method developed by Li
et al. [74] with minor modification. The analysis method
was validated and exceeds the minimum standards
recommended in the Food and Drug Administration
guidance. Briefly, 1 ml 75 % ethanol and 10 ng internal
standard ([2H5]3keto-petromyzonol sulfate; Bridge Organic
Inc., Vicksburg, MI, USA) was added to the whole liver
(24.9 ± 1.7 mg). Liver tissues were homogenized and
incubated in a shaker with 70 rpm at room temperature
overnight. The homogenized tissues were then centrifuged
at 13,000 × g for 10 min. The supernatant was transferred
to a new tube, freeze-dried overnight, and stored at −20 °C
until analyses. Samples were reconstituted in 1 mL of
methanol:water (1:1) and placed in an autosampler for LC-
MS/MS analysis.
Real-Time Quantitative PCR (RTQ-PCR)
RTQ-PCR was performed using the TaqMan MGB or
SYBR Green system (Life Technologies) as described
previously [29]. Gene sequences were obtained from the
sea lamprey genome as described previously [75]. Syn-
thetic oligos were used as standards and run simultan-
eously on the sample plate. The sequences for standards,
primers and TaqMan MGB probe for each mRNA are
listed below. Briefly, total RNA was extracted using TRI-
zol Reagent (Life Technologies), and treated with the
TURBO DNA-free kit (Life Technologies). RNA samples
were then reverse-transcribed into cDNA using M-MLV
reverse transcriptase (Life Technologies) and random
hexamers (Promega Corp.; Madison, WI, USA). Each
RTQ-PCR reaction consisted of 2 μl (5 ng/ μl) cDNA,
8 μl TaqMan or SYBR Green Universal PCR master mix,
900 nM each forward and reverse primers, and 250 nM
TaqMan MGB probe (for TaqMan MGB system only).
Amplification plots were analyzed on an ABI 7900 real-
time PCR thermal cycler (Life Technologies). 40S and
60S ribosomal RNAs were used as internal standards
and were confirmed not to change in expression levels
among treatment groups.
For each gene, the following information is shown:
gene name and synthetic oligo used as the standard for
RTQ-PCR. 5′ and 3′ primer sequences are underlined.
(Note: the 3′ primer is complementary to the sequence
shown). TaqMan MGB probes are shown in uppercase.
40S ribosomal protein: 5′acctacgcaggaacagctatgac
cATCTCGAGCAGCTGAAgctccaatgtggtggaattcgtcg3′.








Hgf (using SYBR Green method, no probe was used):
5′cggcattgcttggaaggaaaaggggaaaattaccgcggccttgtgaacaaaac
agccaccgac3′. Hsp90:
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